目前国内吡唑醚菌酯已登记有58个原药、86个单剂、135个混剂,在登记过程中的产品有1480个,其中单剂470个,混剂1010个,从登记角度来看,吡唑醚菌酯存在严重的抗性风险。同时,从产品抗性特点来看,吡唑嘧菌酯的抗性是非可逆性的,它抗性水平的发生不像三唑类杀菌剂是5倍、10倍的逐渐发生,吡唑醚菌酯的抗性一旦发生,抗性水平直接是1000倍。所以当抗性出 At present, pyrazole ether ester has been registered 58 original drugs, 86 single agents, 135 mixed agents, the registration process in the product has 1480, of which 470 single agent, mixing 1010, from the registration point of view Look, pyraclostrobin there is a serious risk of resistance. At the same time, from the point of view of product resistance, pyraclostrobin resistance is irreversible, its resistance level does not occur as 5 times that of triazole fungicides, 10 times gradually, pyraclostrobin Once the ester resistance has occurred, the level of resistance is 1000 times directly. So when resistant out